GeoVax Awarded NIH Fast Track Phase I/II Grant to Advance Lassa Fever Vaccine
April 10, 2018 09:00 ET
|
GeoVax, Inc.
Deadly epidemic continues in Nigeria; Lassa virus remains endemic in West Africa ATLANTA, GA, April 10, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing...
GeoVax Recognized as “Best Biotech” at Vaccine Industry Excellence Awards during World Vaccine Congress
April 05, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, April 05, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, is honored to announce that it won “Best Biotech” at the World...
GeoVax Provides Vaccine Development Update
March 28, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, March 28, 2018 (GLOBE NEWSWIRE) --
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines using its novel platform technology, today...
GeoVax’s Chief Scientific Officer to Speak at World Vaccine Congress
March 26, 2018 09:00 ET
|
GeoVax, Inc.
GeoVax Also Nominated for Vaccine Industry Excellence Awards Atlanta, GA, March 26, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines,...
GeoVax Reports 2017 Year-End Financial Results
March 23, 2018 15:00 ET
|
GeoVax, Inc.
ATLANTA, March 23, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB:GOVX), a biotechnology company developing innovative human vaccines using its novel platform technology, today announced its...
GeoVax and CaroGen to Collaborate On Development of Therapeutic Hepatitis B Vaccine
February 07, 2018 09:00 ET
|
GeoVax, Inc.
Targeting Chronic Hepatitis B Infections Affecting More Than 240 Million People Worldwide ATLANTA, GA, Feb. 07, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company...
GeoVax to Present at the 2018 ASM Biothreats Conference
January 31, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Jan. 31, 2018 (GLOBE NEWSWIRE) --
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its Chief Scientific Officer, Farshad...
GeoVax Publishes Ebola Vaccine Study Results in Nature’s Scientific Reports
January 16, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Jan. 16, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced publication of its manuscript entitled “A...
GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program
January 03, 2018 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Jan. 03, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with Vaxeal Holding SA on...
GeoVax to Present During China Showcase at Biotech Showcase 2018
January 02, 2018 12:00 ET
|
GeoVax, Inc.
Part of Larger Corporate Partnering Effort During the J.P. Morgan 36th Annual Healthcare Conference ATLANTA, GA, Jan. 02, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a...